What You Should Know:
- Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) announced it raised $5M in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market. The round was led by Osage Venture Partners with additional investment from Royal Street Ventures and Narrow Gauge Ventures.
- The new funding will be used to expand
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More
PointClickCare & Pfizer Launches Real World Data Collaboration
What You Should Know:
- PointClickCare announced a collaboration with Pfizer Inc. to provide real-world insights for vulnerable populations at high risk of age-related disorders (including Cachexia) – further enhancing PCC’s mission to protect and support the senior population.
- With coverage approaching 70% of the long-term and post-acute care (LTPAC) market, PointClickCare is uniquely positioned to provide life sciences companies, like Pfizer, with outcomes-based evidence through
Read More
Forrester Unveils 5 Healthcare Predictions for 2023
What You Should Know:
- A new dawn is on the horizon in healthcare. Equipped with new digital capabilities and pressured by new consumer expectations for personalized, convenient experiences, healthcare organizations face a predicament — act now and stay afloat, fail to act and get consumed by the competition, or risk financial ruin.
- Market research leader Forrester’s latest report explores 5 key predictors for healthcare in 2023.
Healthcare in the Era Post-Covid
COVID-19
Read More
3 Reasons to Implement an IDMP Solution Early
The European Union (EU) has announced guidance on the Identification of Medicinal Product (IDMP) — and pharmaceutical companies around the world should take notice. While the EU will be the first to design and implement IDMP, other countries, including the United States, will need to begin following suit. It’s imperative that companies begin evaluating what changes need to be implemented, and the sooner pharmaceutical companies act, the better.
Designed to connect data elements and
Read More
Medidata Expands Sensor Cloud Network
What You Should Know:
- Medidata, a Dassault Systèmes company, and Boehringer Ingelheim, today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata, Medidata’s suite of patient-facing technologies focused on enhancing patient centricity and diversity in decentralized clinical trials (DCTs).
- The
Read More
The Gains and Pains of Using AI in the Pharmaceutical Industry
The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster.
A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More
ObvioHealth & Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC
What You Should Know:
- Today, ObvioHealth and Oracle have announced a partnership to enable the rapid collection, integration and analysis of this complex data to get breakthrough therapies to market faster and cheaper within the APAC region. This partnership will integrate ObvioGo, ObvioHealth’s next generation decentralized clinical trial (DCT) platform and mobile app, and Oracle Clinical One Cloud Service, facilitating pharma-grade analytics and reporting that can
Read More
SURGE Therapeutics Raises $26M to Accelerate Intraoperative Immunotherapy
What You Should Know:
- SURGE Therapeutics (SURGE) recently announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute.
- The funds will be used to accelerate the development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel.
Using
Read More
Eclipse and Mayo Clinic Create Nucleus RadioPharma for Cancer Patients
What You Should Know:
- Eclipse, a venture capital firm investing in the digital transformation of the world's physical industries, and Mayo Clinic, a leading nonprofit health organization, recently announced the creation and seed funding of Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new
Read More
